Written Question·Department of Health and Social Care·UIN 97025
Cosmetics: Afamelanotide
Tabled: 3 December 2025
Answered: 15 December 2025
Question
Olivia Blake
Labour — Sheffield Hallam
To ask the Secretary of State for Health and Social Care, who has responsibility for preventing the availability of products containing Melanotan II in England; and what steps he has taken to tackle the availability of these products.
Answer
Dr Zubir AhmedThe Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis taking into account the definition of a medicine in The Human Medicines Regulations 2012, relevant case law, and...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 97025) →